Stay updated on ARO-HIF2 in Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the ARO-HIF2 in Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARO-HIF2 in Renal Cell Carcinoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page displays the ARO-HIF2 clinical trial record, including its study design, eligibility criteria, locations, outcomes, and record dates.
    Difference
    44%
    Check dated 2026-11-08T23:24:52.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.8.0 instead of v3.7.2. The study page still shows a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T23:27:58.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A notice was added announcing NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology, with links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T22:47:17.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The displayed ClinicalTrials.gov revision advances from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T23:05:12.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T23:17:59.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Introduces a 403 Forbidden error page for the study record, with a simple header and a Home button, indicating the page is inaccessible. The update also displays the site revision version (Revision: v3.7.0).
    Difference
    17%
    Check dated 2026-09-20T22:34:05.000Z thumbnail image

Stay in the know with updates to ARO-HIF2 in Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARO-HIF2 in Renal Cell Carcinoma Clinical Trial page.